CarthroniX
Biopharmaceutical innovations for degenerative diseases, focusing on cartilage repair, inflammation suppression, and skin regeneration.
HQ location
Los Angeles, United States
Website
Launch date
Employees
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $2.3m | Convertible | |
| Total Funding | 000k | ||
Related Content
Notes (0)
More about CarthroniX
EditMade with AI
CarthroniX is a biopharmaceutical company focused on developing small molecule-based therapies for cartilage diseases, including arthritis. Our novel technologies are able to preserve, repair and regenerate cartilage in joints and concurrently suppress inflammation. Our discoveries are based on science conducted by world-class researchers at iconic institutions. We are CarthroniX; we are the future.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads